Plasma membrane Ca2+ ATPase 4 is required for sperm motility and male fertility. by Schuh, Kai et al.
Plasma Membrane Ca2 ATPase 4 Is Required for
Sperm Motility and Male Fertility*
Received for publication, November 18, 2003, and in revised form, March 31, 2004
Published, JBC Papers in Press, April 12, 2004, DOI 10.1074/jbc.M312599200
Kai Schuh‡§, Elizabeth J. Cartwright¶, Eriks Jankevics, Karin Bundschu‡,
Ju¨rgen Liebermann**, Judith C. Williams¶, Angel L. Armesilla¶, Michael Emerson¶,
Delvac Oceandy¶, Klaus-Peter Knobeloch‡‡, and Ludwig Neyses¶§§
From the ‡Institute for Clinical Biochemistry and Pathobiochemistry, University of Wuerzburg, Josef-Schneider-Strasse 2,
D-97080 Wuerzburg, Germany, the Biochemical Research and Study Center, University of Latvia, Ratsupites iela 1, Riga,
LV-1067, Latvia, the **Department of Obstetrics and Gynecology, University of Wuerzburg, Josef-Schneider-Str. 2,
D-97080 Wuerzburg, Germany, the ‡‡FMP, Krahmerstrasse 6, D-12207 Berlin, Germany, and the ¶Division of Cardiology,
Room 1.302 Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PT, United Kingdom
Calcium and Ca2-dependent signals play a crucial role
in sperm motility and mammalian fertilization, but the
molecules and mechanisms underlying these Ca2-
dependent pathways are incompletely understood. Here
we show that homozygous male mice with a targeted gene
deletion of isoform 4 of the plasma membrane calcium/
calmodulin-dependent calcium ATPase (PMCA), which is
highly enriched in the sperm tail, are infertile due to
severely impaired sperm motility. Furthermore, the
PMCA inhibitor 5-(and-6)-carboxyeosin diacetate succin-
imidyl ester reduced sperm motility in wild-type animals,
thus mimicking the effects of PMCA4 deficiency on sperm
motility and supporting the hypothesis of a pivotal role of
the PMCA4 on the regulation of sperm function and intra-
cellular Ca2 levels.
Successful fertilization requires the sperm to travel long
distances and undergo capacitation prior to reaching the
female egg. After reaching their target, the sperm must in-
teract with the extracellular matrix of the egg, including
proteins of the zona pellucida, and release acrosomal mate-
rial. Calcium is considered to exert a function on most, if not
all, of these processes. In this field, most of the work on Ca2
signaling has focused on Ca2 entry mechanisms, especially
on the role of Ca2 channels (1–4). For example, gene abla-
tion of the cation channel of sperm (CatSper) leads to im-
paired sperm motility and male infertility (5), and mice lack-
ing the mitochondrial voltage-dependent anion channel type
3 (VDAC3) are also infertile due to immotile sperm (6). These
results show that tight regulation of ion entry by
ion channels is critical to sperm function. Although there is
little doubt as to the importance of calcium homeostasis in
sperm motility and fertilization (7–12), the function of the
plasma membrane Ca2/calmodulin-dependent Ca2 ATPase
(PMCA)1 during this process remained enigmatic.
PMCA represents a family of enzymes that extrude calcium
from the cytosol across the plasma membrane of eukaryotic
cells. Since their initial identification in erythrocytes (13), four
different isoforms have been identified, and multiple splice
forms of these isoforms have been described. The well defined
tissue-specific expression pattern of different isoforms and
splice variants of the pump in various mammalian tissues (14)
and the regulated expression pattern during mouse develop-
ment (15) strongly suggest a specific physiological function for
each isoform and splice variant (reviewed in Strehler and
Zacharias (16)). The identification of physical and functional
interaction partners of the Ca2 pump has given insights into
the putative functions of PMCAs as regulators of Ca2-depend-
ent signal transduction processes (17–21). Interaction of
PMCA2 and -4 “b” splice variants was shown to be mediated by
the PDZ-(PSD-95/Dlg/ZO-1) domain of the corresponding inter-
action partner and the C termini of the PMCA isoform (which
harbors a typical PDZ domain binding motif (17)). Both modes
of interaction with PDZ domain-containing proteins, specific
and promiscuous binding to different PDZ domains, have been
demonstrated (18, 19). In addition to the overlapping expres-
sion pattern of the four PMCA isoforms and the diversity gen-
erated by alternative splicing, the specificity of interaction with
other proteins adds a further level of complexity in determining
the physiological functions of each isoform.
Gene ablation in mice using homologous recombination in
embryonic stem cells represents one possibility to evaluate the
function of proteins in vivo and to address the isoform-specific
functions of a certain protein. This strategy has been success-
fully used to generate PMCA2-deficient mice that suffer from
deafness and balance deficits (22), supported by analyses of
“deafwaddler” and “wriggle mouse Sagami” mouse strains, both
showing a phenotype comparable with the PMCA2-deficient
mice and also harboring spontaneous mutations in the PMCA2
gene (23, 24).
To clarify the in vivo function of PMCA4, we generated
PMCA4-deficient mice and studied the physiological effects of
this gene deficiency. PMCA4 deficiency does not impair devel-
opment to adulthood but leads to male infertility due to im-
paired sperm motility.
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FIG. 1. Sequence comparison of mouse PMCA4 with human and rat PMCA4. A, sequence comparison of PMCA4b splice variants of mouse,
human, and rat revealed high homology (boxed) of the entire corresponding proteins as well as conservation of the C-terminal PDZ domain binding
motif. B, sequence comparison of C termini (c term) of mouse, human, and rat PMCA4a splice variants demonstrating homology of PMCA4a
variants.
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EXPERIMENTAL PROCEDURES
Cloning of Mouse PMCA4 Isoforms—Mouse PMCA4 isoforms were
cloned by rapid amplification of cDNA ends from a mouse testis Mara-
thon-ReadyTM double-stranded cDNA library (catalog number 7455-1,
Clontech) using the Advantage® 2 PCR system (Clontech) and the
following gene-specific primers: mouse PMCA4 forward, 5-GTC TGA
TCA TGT CTG TCC TCA CAG TTG-3, and mouse PMCA4 reverse,
5-GCA GCC CCT CTG GCA CAG CCA CT-3. Polymerase chain reac-
tion was performed as suggested by the manufacturer, and the result-
ing PCR fragments were cloned into pCR®-XL-TOPO vector (Invitro-
gen) and subsequently sequenced with the standard T7 and M13
reverse primers. The resulting sequences were analyzed and aligned
with DNAMAN 4.0 software (Lynnon BioSoft), and the transmembrane
helices were predicted with HMMTOP Version 2.0 at www.enzim.hu/
hummtop (25). Mouse PMCA4b and -4a sequences have been deposited
in GenBankTM, and the accession numbers are AY560895 and
AY560896, respectively.
Northern Blotting and Immunofluorescence Stainings—To deter-
mine the expression pattern of PMCA4 in mouse testis, we hybridized
the MessageMapTM Northern blot (each lane containing 2 g of
poly(A) RNA, Stratagene, catalog number 776900) with the 32P-dATP-
labeled full-length PMCA4b cDNA according to the manufacturer’s
protocol and reprobed the subsequently stripped membrane with a
32P-dATP-labeled -actin probe. The subcellular distribution of
PMCA4b was determined by immunofluorescence stainings. Isolated
sperm were allowed to swim out from cauda epididymidis in sperm
preparation buffer (MediCult, catalog number 10680060) for 15 min,
and the suspension was streaked out on poly-lysine-coated slides, air-
dried for 10 min, and fixed and stained as described previously (21). The
PMCA4-specific polyclonal antiserum was also described previously
(26).
Generation of PMCA4-deficient Mice—A 12-kb genomic DNA frag-
ment containing exons 2–4 of the mouse PMCA4 gene was isolated from
a 129Sv mouse genomic library in the FixTMII vector (Stratagene). The
targeting vector was generated by inserting the homologous BglII/KpnI
and BspMII/NotI fragments into the pPNT vector (27) (Fig. 3A). 20 g
of linearized targeting vector was electroporated into E14.1 embryonic
stem cells. Neomycin- and ganciclovir-resistant clones (500 g/ml G418
and 2 M ganciclovir) were screened for homologous recombination by
Southern blot using the external BamHI/BglII fragment of the mouse
PMCA4 gene as a probe (Fig. 3A). This probe hybridizes to a 7.0-kb
BamHI fragment (endogenous pmca4 allele) and a 3.3-kb fragment
(disrupted allele). Embryonic stem cells that had undergone homolo-
gous recombination were injected into C57Bl/6 blastocysts, and the
manipulated blastocysts were transferred into pseudo-pregnant foster
mice to generate chimeras. Chimeric males were mated to C57Bl/6
females to test for germ line transmission of the targeted PMCA4 allele.
PMCA4-deficient mice were obtained by appropriate inbreeding of het-
erozygous offspring and subsequent genotyping.
RT-PCR and Western Blotting—The absence of PMCA4 mRNA in
PMCA4-deficient mice was tested by RT-PCR using the OneStep RT-
PCR kit (Qiagen) and the following PMCA4-specific (not species-spe-
cific) primers: PMCA4 forward, 5-CTG AGG AAG CTC ATGGAG C-3,
and PMCA4 reverse, 5-CGG AAA/G TGC TTC TCT TTG C-3. To test
for the absence of PMCA4 at the protein level in sperm, isolated sperm
from one cauda epididymidis were collected by centrifugation and boiled
for 5 min in 200 l of Laemmli sample buffer (Bio-Rad). 20 l of each
lysate was separated on a 10% SDS-PAGE, blotted onto a nitrocellulose
membrane (Schleicher & Schuell), and the membranes were cut at the
level of the 75-kDa protein marker band. The upper half was tested for
PMCA4 expression using the PMCA4-specific monoclonal antibody JA9
(28) (NeoMarkers, 1:500 dilution), and the lower half was probed for
actin (polyclonal goat anti-actin, Santa Cruz Biotechnology, catalog
number sc-1616, 1:500 dilution) to check for equal loading of the sam-
ples. Blocking and antibody incubations were done with 5% milk in
phosphate-buffered saline/0.05% Tween 20. Signals were detected with
specific horseradish peroxidase-labeled secondary antibodies and the
ECL detection system (Amersham Biosciences).
Tissue Sections of Testis and Histological Stainings—Tissue sections
were frozen and prepared as described previously (21) and stained with
hematoxylin and eosin using a standard protocol. Cytological staining
of mouse sperm was carried out using SpermacStainTM (Stain Enter-
prises Inc.) according to the manufacturer’s instructions.
In Vitro Fertilization—Sperm were collected from cauda epididymi-
dis in sperm preparation buffer (MediCult) and capacitated in vitro for
2 h at 37 °C. Oocytes were prepared from C57Bl/6 females that had
been synchronized with 10 units of pregnant mare serum gonadotropin
(Sigma) and 10 units of human chorionic gonadotropin (Sigma) 48 and
14 h prior to oocyte collection. Eggs were flushed from oviducts in M2
medium (Sigma) and cultivated in M16 medium (Sigma) in 5% CO2 at
37 °C. In vitro fertilization capacity was tested as described previously
(29). In brief, eggs were incubated with 105 wild-type or 105 PMCA4-
deficient sperm for 24 h at 37 °C, and eggs that had divided to the
two-cell stage were counted as indicative of successful fertilization.
Estimation of Sperm Motility and Measurement of Intracellular Cal-
cium—Sperm were collected from cauda epididymidis as described
above. The supernatant containing sperm was decanted into a fresh
tube, and the cells were left untreated at 37 °C for 30 min or loaded with
the PMCA inhibitor 5-(and 6)-carboxyeosin diacetate succinimidyl ester
(10 M, Molecular Probes).
Overall sperm motility was estimated using the medeaLAB CASA
4.2 system (Erlangen) optimized for mouse sperm. Morphology and
tracking threshold upper levels were set to: red 255, green 90, and blue
255, respectively. Additionally, all possible form parameters were de-
activated (e.g. flagellum detection, color, and others), and area and form
factor filters have been left unchanged. In addition to the classification
of sperm motility, average path velocity, progressive velocity, and track
speed were calculated with statistical analysis of raw motility data.
To estimate intracellular Ca2 levels in capacitated sperm, they were
prepared in sperm preparation buffer (MediCult) as described above,
capacitated for 30 min, and loaded with 10 M Fluo-4-AM for 30 min at
37 °C. The cells were subsequently washed, counted (Coulter counter),
and resuspended at a concentration of 1  107 cells/ml in sperm prep-
FIG. 2. Expression of PMCA4 in mouse testis and in sperm. A,
Northern blot demonstrating expression of PMCA4 in mouse testis.
Approximately 50 pg of PMCA4 cDNA was spotted onto the membrane
as positive control (pos. control). Loading control: -actin. Sk. Muscle,
skeletal muscle. B–E, localization of PMCA4b to the principal piece of
the tail and acrosome region of mouse sperm as follows. B, phase
contrast micrograph of wild-type sperm. C, staining of PMCA4 in the
same sperm with polyclonal PMCA4-specific antibodies and CyTM3-
labeled secondary antibody. D, phase contrast of control staining of
wild-type sperm. E, control staining with secondary antibody alone,
showing no unspecific staining.
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aration buffer supplemented with 2 mM CaCl2. Changes in fluorescence
were recorded with an excitation wavelength of 494 nm and emission
wavelength of 516 nm with a PerkinElmer Life Sciences LS 50 B
fluorescence photometer using the time drive protocol of the FL Winlab
2.00 software. Intracellular Ca2 levels after the capacitation period
were calculated based on a given dissociation constant KD(Ca
2)  345
nM of Fluo-4 (Molecular Probes). For calculation of intracellular calcium
levels, maximum fluorescence was induced with 50 M calcium iono-
phore A3187, and minimal fluorescence was estimated in the presence
of 2 mM EDTA in sperm preparation buffer.
RESULTS AND DISCUSSION
Full-length cDNA of mouse PMCA4b splice variant and the C
terminus of mouse PMCA4a variant were cloned from a testis
cDNA library by rapid amplification of cDNA ends (5 and 3
rapid amplification of cDNA ends. Comparison of predicted
protein sequences with human (30) and rat (31) PMCA4b and
-4a revealed a high degree of homology (Fig. 1). Mouse
PMCA4b contains 10 predicted transmembrane domains, form-
ing a pore in the plasma membrane, which is a typical feature
of PMCAs. The C terminus of mouse PMCA4b harbors a typical
PDZ domain binding motif (amino acid sequence: . . . ETPV),
most presumably mediating specificity of binding to certain
PDZ domains, as shown previously for other human PMCA b
splice variants (17–21, 32).
The C terminus of mouse PMCA4a has a high level of simi-
larity to “a” splice variants of other species (Fig. 1; rat
PMCA4a: . . . PPMGNCSGQSVP, human PMCA4a: . . .
PPVGNQSGQSIS, mouse PMCA4a . . . PPVGNCSRQTVP).
However, the molecular function of this C-terminal PMCA4a
motif remains unclear.
Although previously shown to be expressed in several organs
(14), multiple tissue Northern blot analysis revealed prominent
expression of the PMCA4 messenger RNA in mouse testis (Fig.
2A). In addition, although the relative actin mRNA contents of
various tissue types are most likely different, the prominent
PMCA4 signal in Fig. 2A suggests robust expression of PMCA4
in mouse testis.
A polyclonal antibody directed against the N-terminal part of
PMCA4 and cross-reactive with mouse PMCA4 (26) was used to
determine subcellular localization of PMCA4 protein in wild-
type mouse sperm. The protein was expressed in the principal
piece of the sperm tail, the flagellar apparatus propelling the
spermatozoon forward, and to a lesser extent to the sickle-
shaped mouse sperm acrosome region (Fig. 2B). Interestingly,
the recently described sperm-specific calcium channel CatSper
was also localized in the principal region of the tail, and its
gene deletion leads to severely reduced sperm motility and
male infertility, thus underlining the important role of Ca2
signaling in sperm motility (5).
To study the physiological function of PMCA4 in vivo, we
disrupted the PMCA4 gene in embryonic stem cells by homol-
ogous recombination (Fig. 3A). The second exon and part of the
third exon were replaced by the neomycin resistance cassette.
Following homologous recombination, embryonic stem cells
were injected into blastocysts and implanted into pseudo-preg-
FIG. 3. Generation of PMCA4-defi-
cient mice. A, targeted disruption of
PMCA4. Partial genomic structure of the
mouse PMCA4 gene as identified by se-
quencing of  phage insert, subcloned
HindIII/NotI fragment HN28 used for
construction of targeting vector, targeting
vector, and disrupted PMCA4 gene. The
BamHI/BglII fragment was used as probe
to test for homologous recombination and
genotyping of offspring. ko, knock-out. wt,
wild-type. B, Southern blot showing geno-
typing of heterozygous (lane 2), wild-type
(lane 3), and knock-out (lane 4) offspring.
Lane 1, DNA marker used to identify
fragment sizes. C, RT-PCR using PMCA4-
specific primers showing the absence of
PMCA4 mRNA in sperm of PMCA4-defi-
cient mice. M, mutant. D, Western blot
demonstrating the absence of PMCA4 in
testis of PMCA4-deficient mice. The up-
per panel demonstrates lack of PMCA4
protein in isolated sperm, and in the
lower panel, equal loading of proteins was
demonstrated by detection of actin in the
sperm lysates.
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nant foster mice. Following germ line transmission of the mu-
tation, PMCA4-deficient mice were obtained by cross-breeding
heterozygous offspring. Disruption of the PMCA4 gene was
confirmed by Southern blotting (Fig. 3B), and the absence of
the mRNA transcript and of the protein was shown by RT-PCR
and Western blot analysis (Fig. 3, C and D).
Offspring of mated heterozygous males and females were
born in the expected Mendelian ratio (26.2% /, 46.3% /,
27.5% /), suggesting that PMCA4 deficiency did not affect
embryonic development. PMCA4/ mice were indistinguish-
able from their wild-type littermates with respect to body
weight, appearance, and gross behavior. Adult PMCA4/ fe-
males, mated with wild-type or heterozygous PMCA4/
males, did not show alterations in fertility (100% fertile). How-
ever, a homozygous PMCA4-deficient line could not be estab-
lished when both homozygous males and females were crossed.
Appropriate homo-/heterozygote cross-breeding demonstrated
normal female and absent male fertility; 10 PMCA4/ males
engendered no pregnancies over a period of up to 6 months.
Alterations in mating behavior or erectile dysfunction were
excluded because after mating homozygous knock-out males
with PMCA4-deficient females, the latter had a normal fre-
quency of vaginal sperm plugs.
A closer microscopical examination of testes and sperm re-
vealed no histological differences in testes architecture and no
morphological differences in sperm of PMCA4/ mice and
their wild-type littermates (Fig. 4, A and B). In vitro fertiliza-
tion assays were performed to test the ability of PMCA4-defi-
cient sperm to fertilize eggs. 38% (10 of 24) of eggs incubated
with capacitated wild-type sperm and 35% (11 of 30) of eggs
incubated with PMCA4-deficient sperm reached the two-cell-
stage after 24 h (example in Fig. 4C). PMCA4-deficient sperm
were also able to bind to empty zona pellucida, suggesting that
these sperm undergo the normal acrosome reaction (example in
Fig. 4C). To gain a first insight into the regulation of intracel-
lular calcium of PMCA4-deficient sperm after capacitation, we
have estimated the intracellular calcium after preparation and
60-min capacitation of sperm from caudae epididymides from
PMCA4-deficient mice in comparison with sperm of their wild-
type littermates. Assuming a KD(Ca
2) of 345 nM for Fluo4, the
average intracellular calcium concentration of wild-type sperm
was found to be 157 nM, and the intracellular calcium in knock-
out sperm was 370 nM (example of one recording given in Fig.
4D, in total n  15, p  0.05). This underlines the previously
suggested pivotal role of the PMCA in the regulation of basal
calcium levels and calcium clearance in sperm (33), but de-
tailed analyses of the regulation of intracellular free calcium in
different compartments of sperm have to be made to under-
stand the functions of the PMCA4 in the fertilization process.
As a consequence of the genetic manipulation, an obvious
difference in the motility of mutant and wild-type sperm was
observed. Sperm were classified by standard clinical tests for
sperm motility disorders with a computer-aided sperm analysis
system; a large number of PMCA4-deficient sperm were immo-
tile (68%), displayed extremely low directed progressive motil-
ity (14%), or showed no directed movement (18%) as compared
with sperm of wild-type littermates (7% immotile, 73% progres-
sive motility, 20% no directed motility, examples of recordings
in Fig. 5, A and B). Analysis of main motility parameters
showed that average path velocity, progressive velocity, and
track speed were severely impaired in PMCA4-deficient mice
(Fig. 5D).
If deletion of PMCA4 leads to strongly impaired sperm mo-
tility, it should conceptually be possible to mimic this effect by
FIG. 4. Morphology and function of
PMCA4/ testis and PMCA4-defi-
cient sperm. A, hematoxylin/eosin stain-
ing of testis sections did not show histo-
logical differences between PMCA4/
and wild-type (WT) littermate controls.
KO, knock-out. B, no obvious cytological
differences were observed in bright field
microscopy of previously stained, isolated
sperm (63 objective, oil immersion,
SpermacStain® staining). C, no signifi-
cant differences in in vitro fertilization
capacity of wild-type (upper panel) and
PMCA4-deficient sperm (middle panel)
were observed. PMCA4-deficient sperm
were able to attach to empty zona pellu-
cida, suggesting normal acrosome reac-
tion (lower panel). D, example of one re-
cording of change in intracellular calcium
in response to 50 M Ca2 ionophore
A23187. PMCA4-deficient sperm (red)
showed an elevated resting intracellular
Ca2 concentration [Ca2]i and approxi-
mately the same maximal Ca2 concen-
tration in response to ionophore A23187
as the wild-type control sperm (blue). To
estimate intracellular calcium, similar re-
cordings in the presence of EDTA have
been made (not shown), and the intracel-
lular free calcium levels have been calcu-
lated. Time in seconds, relative inten-
sity  relative intensity of fluorescence.
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using the cell-permeable PMCA inhibitor 5-(and-6)-carboxyeo-
sin diacetate succinimidyl ester (CE). 10 M CE severely re-
duced the motility of wild-type sperm (36% immotile, 30%
progressive motility, 34% no directed motility, examples of
recordings in Fig. 5C, analysis of main motility parameters in
Fig. 5D), providing additional evidence for the importance of
PMCA activity in the regulation of sperm motility. CE in the
concentration range of 10–20 M has been shown previously to
be an effective, specific inhibitor of the plasma membrane
calcium pump (34–36).
In conclusion, we describe a highly specific form of male
infertility in animals with a deletion of the PMCA4 gene. The
latter is crucial to sperm motility but not to in vitro fertilization
capacity. The PMCA inhibitor 5-(and-6)-carboxyeosin diacetate
succinimidyl ester mimics the effect of gene deletion on sperm
motility. Therefore, it may act as an ideal lead compound for
the development of contraceptive drugs and has a number of
chemically active side groups that can potentially be used for
modification, for example to enhance accumulation in the testis
or seminal vesicles and reduce potential side effects. Little is
known about the toxicity of 5-(and-6)-carboxyeosin diacetate
succinimidyl ester, but the parent compounds eosin and fluo-
rescein are extensively used as a colorant in cosmetics and for
diagnostic purposes, respectively, and therefore, they represent
a promising class of lead compounds for further contraceptive
drug development. Conceptually, our findings may open the
way to a novel form of non-hormonal contraception. Further-
more, our findings make PMCA4 a candidate gene for the
analysis of genetic and environmental causes of male infertil-
ity, an increasing problem globally (37, 38).
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